Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
前日終値
$27.69
−$0.11 · -0.40%
日中の時刻はETです。市場データは遅延する場合があります。
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
日中レンジ
現在 $27.69
52週レンジ
現在 $27.69
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
85
大幅な割安
センチメント
50
まちまち
リスク
30
中程度のリスク
モメンタム
92
強い上昇
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
日中レンジ
現在 $27.69
52週レンジ
現在 $27.69
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 7377.6万 USD | 6400万 USD | 5471.6万 USD | 4806.7万 USD | 4165.9万 USD |
| 売上原価 | 1583.3万 USD | 1402.9万 USD | 1299万 USD | 1154.8万 USD | 1021.7万 USD |
| 粗利益 | 5794.3万 USD | 4997.1万 USD | 4172.6万 USD | 3651.9万 USD | 3144.2万 USD |
| 研究開発 | 131.4万 USD | 99.6万 USD | 65.6万 USD | 91.6万 USD | 135.6万 USD |
| 販売・一般管理 | 4274.8万 USD | 3910.3万 USD | 3448.9万 USD | 3159.5万 USD | 2711.4万 USD |
| 営業費用 | 4406.2万 USD | 4009.9万 USD | 3514.5万 USD | 3251.1万 USD | 2847万 USD |
| 受取利息 | 47.9万 USD | 62.4万 USD | 45.5万 USD | 7.8万 USD | 2.5万 USD |
| 減価償却費と償却費 | 107.6万 USD | 117.2万 USD | 84.1万 USD | 61.3万 USD | 62.8万 USD |
| 営業利益 | 1388.1万 USD | 987.2万 USD | 658.1万 USD | 400.8万 USD | 297.2万 USD |
| 純利益 | 1130.1万 USD | 753.7万 USD | 515万 USD | 316.6万 USD | 230.5万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI551.39万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM485.11万0.01%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF228.36万0.00%954億 USD0.05%$235+0.80%
Dimensional - US Small Cap ETFDFAS204.09万0.01%338.69億 USD0.31%$78.35+0.32%
iShares Russell 2000 Growth ETFIWO173.68万0.01%139.17億 USD0.24%$356.78+0.94%
Fidelity Small-Mid Multifactor ETFFSMD143.21万0.06%24.9億 USD0.15%$49.96+0.48%
Vanguard Russell 2000 ETFVTWO106.87万0.01%180億 USD0.06%$112.66+0.50%
U.S. Micro Cap Portfolio ETFDFMC82.78万0.01%75.58億 USD0.43%$57.813+0.20%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
iShares Russell 2000 Growth ETFIWO
Fidelity Small-Mid Multifactor ETFFSMD
Vanguard Russell 2000 ETFVTWO
U.S. Micro Cap Portfolio ETFDFMCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。